111 related articles for article (PubMed ID: 29734545)
1. Depressive symptoms' pattern in postmenopausal women.
Slopień R; Slopień A; Pawlak M; Warenik-Szymankiewicz A; Sajdak S
Clin Exp Obstet Gynecol; 2016; 43(4):544-545. PubMed ID: 29734545
[TBL] [Abstract][Full Text] [Related]
2. Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.
Slopien R; Pluchino N; Warenik-Szymankiewicz A; Sajdak S; Luisi M; Drakopoulos P; Genazzani AR
Gynecol Endocrinol; 2018 Feb; 34(2):144-147. PubMed ID: 28857628
[TBL] [Abstract][Full Text] [Related]
3. Serum prolactin concentration and severity of depression symptoms in climacteric women.
Słopień R; Słopień A; Warenik-Szymankiewicz A
Clin Exp Obstet Gynecol; 2015; 42(6):749-51. PubMed ID: 26753478
[TBL] [Abstract][Full Text] [Related]
4. The assessment of the relationship between personality, the presence of the 5HTT and MAO-A polymorphisms, and the severity of climacteric and depressive symptoms in postmenopausal women.
Jurczak A; Szkup M; Wieder-Huszla S; Grzywacz A; Samochowiec A; Karakiewicz B; Samochowiec J; Grochans E
Arch Womens Ment Health; 2015 Aug; 18(4):613-21. PubMed ID: 25655492
[TBL] [Abstract][Full Text] [Related]
5. The 5HTT and MAO-A polymorphisms associate with depressive mood and climacteric symptoms in postmenopausal women.
Grochans E; Grzywacz A; Jurczak A; Samochowiec A; Karakiewicz B; Brodowska A; Starczewski A; Samochowiec J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():125-30. PubMed ID: 23707423
[TBL] [Abstract][Full Text] [Related]
6. Depressive symptoms and hormonal profile in climacteric women.
Słopień R; Słopień A; Warenik-Szymankiewicz A; Sajdak S
Clin Exp Obstet Gynecol; 2015; 42(3):285-91. PubMed ID: 26151994
[TBL] [Abstract][Full Text] [Related]
7. Effect of symptoms of climacteric syndrome, depression and insomnia on self-rated work ability in peri- and post-menopausal women in non-manual employment.
Humeniuk E; Bojar I; Gujski M; Raczkiewicz D
Ann Agric Environ Med; 2019 Dec; 26(4):600-605. PubMed ID: 31885234
[TBL] [Abstract][Full Text] [Related]
8. Relationship between climacteric symptoms and serum galanin levels in post-menopausal women.
Słopien R; Meczekalski B; Warenik-Szymankiewicz A
J Endocrinol Invest; 2004 Oct; 27(9):RC21-3. PubMed ID: 15648541
[TBL] [Abstract][Full Text] [Related]
9. Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women.
Słopień R; Meczekalski B; Warenik-Szymankiewicz A
Climacteric; 2003 Mar; 6(1):53-7. PubMed ID: 12725665
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
[TBL] [Abstract][Full Text] [Related]
11. The symptomatology of climacteric syndrome: whether associated with the physical factors or psychological disorder in perimenopausal/postmenopausal patients with anxiety-depression disorder.
Zhou B; Sun X; Zhang M; Deng Y; Hu J
Arch Gynecol Obstet; 2012 May; 285(5):1345-52. PubMed ID: 22124532
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between climacteric symptoms and serum neuropeptide Y level in postmenopausal women].
Słopień R; Meczekalski B; Warenik-Szymankiewicz A
Ginekol Pol; 2003 Sep; 74(9):1023-8. PubMed ID: 14674163
[TBL] [Abstract][Full Text] [Related]
13. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report.
Cohen LS; Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL
Am J Psychiatry; 2003 Aug; 160(8):1519-22. PubMed ID: 12900318
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Sociodemographic, Psychological, and Genetic Factors Contributing to Depressive symptoms in Pre-, Peri- and Postmenopausal Women.
Grochans E; Szkup M; Kotwas A; Kopeć J; Karakiewicz B; Jurczak A
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29642625
[TBL] [Abstract][Full Text] [Related]
15. Associations among depression, anxiety and somatic symptoms in peri- and postmenopausal women.
Terauchi M; Hiramitsu S; Akiyoshi M; Owa Y; Kato K; Obayashi S; Matsushima E; Kubota T
J Obstet Gynaecol Res; 2013 May; 39(5):1007-13. PubMed ID: 23379427
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome.
Chedraui P; Pérez-López FR; Hidalgo L; Villacreses D; Domínguez A; Escobar GS; Genazzani AR; Simoncini T;
Gynecol Endocrinol; 2014; 30(12):918-24. PubMed ID: 25347000
[TBL] [Abstract][Full Text] [Related]
17. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
Kornstein SG; Clayton AH; Bao W; Guico-Pabia CJ
J Womens Health (Larchmt); 2015 Apr; 24(4):281-90. PubMed ID: 25860107
[TBL] [Abstract][Full Text] [Related]
18. Treating insomnia improves depression, maladaptive thinking, and hyperarousal in postmenopausal women: comparing cognitive-behavioral therapy for insomnia (CBTI), sleep restriction therapy, and sleep hygiene education.
Kalmbach DA; Cheng P; Arnedt JT; Anderson JR; Roth T; Fellman-Couture C; Williams RA; Drake CL
Sleep Med; 2019 Mar; 55():124-134. PubMed ID: 30785053
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in postmenopausal women: the impact of depressive and anxiety disorders.
Uguz F; Sahingoz M; Gezginc K; Ayhan MG
Int J Psychiatry Med; 2011; 41(3):281-92. PubMed ID: 22073767
[TBL] [Abstract][Full Text] [Related]
20. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial.
Morrison MF; Kallan MJ; Ten Have T; Katz I; Tweedy K; Battistini M
Biol Psychiatry; 2004 Feb; 55(4):406-12. PubMed ID: 14960294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
